Letter from Malaysia

Respirology. 2021 Jun;26(6):624-626. doi: 10.1111/resp.14057. Epub 2021 Apr 11.

Authors

Syazatul Syakirin Sirol Aflah¹, Alif Adlan Mohd Thabit², Suresh Kumar Chidambaram²

Affiliations

¹ Respiratory Department, Institute of Respiratory Medicine, Kuala Lumpur, Malaysia.
² Infectious Disease Department, Sungai Buloh Hospital, Sungai Buloh, Malaysia.

PMID: 33843115
DOI: 10.1111/resp.14057

No abstract available

Keywords: COVID-19; Malaysia; SARS-CoV-2.

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
COVID-19*
Humans
Malaysia / epidemiology
SARS-CoV-2
World Health Organization

Substances

Antiviral Agents